Clinical trial
A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell…
NCT00034827 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00034827 |
|---|---|
| Title | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer |
| Official title | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung Cancer, Breast Cancer, Colon Cancer, or Pancreatic Cancer |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms |
| Intervention type | Drug |
| Interventions | CI-1040 |
| Enrollment | 172 |
| Start date | Jan 1, 2002 |
| Completion | May 1, 2003 |
| First posted | May 3, 2002 |
| Last update posted | May 4, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: